A Retrospective Study on Personalized Dosing Strategy of Patients Treated by Carbapenems: 2018-2021
NCT05762094 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1000
Last updated 2023-03-15
Summary
Patients may benefit from the personalized carbapenem dosing strategy based on pharmacokinetics. The objective of this study is to retrospectively review and analyze the clinical outcomes of patients with different dosing strategy.
Conditions
Sponsors & Collaborators
-
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-03-31
- Primary Completion
- 2023-12-31
- Completion
- 2023-12-31
Countries
- China
Study Locations
More Related Trials
-
Cefepime vs. Carbapenems for Treating AmpC β-lactamase-producing Enterobacteriaceae Bloodstream Infections
NCT05535751 ·Status: COMPLETED
-
A Pharmacokinetics Study of Daptomycin in Critically Ill Patients and Effects of Daptomycin on Kidney
NCT04277143 ·Status: UNKNOWN
-
Epidemiological Characteristics and Treatment Protocol for Carbapenem-Resistant Klebsiella Pneumoniae in China
NCT03245632 ·Status: UNKNOWN
-
Carbapenems De-escalation as Antimicrobial Stewardship
NCT03114358 ·Status: COMPLETED ·Phase: NA
-
Dose Optimization by Pharmacokinetic/Pharmacodynamic of Antibiotics to Improve Clinical Outcome of Carbapenem Resistant Klebsiella Pneumoniae Bloodstream Infections in Critically Ill Patients at Phramongkutklao Hospital
NCT05862402 ·Status: UNKNOWN ·Phase: PHASE4
-
Comparison of Bloodstream Infections With Carbapenem Hetero-resistant vs Carbapenem Resistant Klebsiella Pneumoniae
NCT04229498 ·Status: UNKNOWN
-
Utility of Vancomycin Loading: A Pharmacokinetic Analysis in Critically Ill Patients
NCT01157533 ·Status: TERMINATED ·Phase: NA
-
Subcutaneous Daptomycin in Healthy Volunteers (DAPTOSC)
NCT04434300 ·Status: COMPLETED ·Phase: PHASE1
-
Therapeutic Drug Monitoring in Patients With Difficult-to-Treat Gram-Negative Bacterial Infections
NCT05942157 ·Status: RECRUITING ·Phase: NA
-
Clinical Efficacy of Combination Therapy Based on High-dose Biapenem in CRKP Infections
NCT04552444 ·Status: UNKNOWN
-
Study on Cefotaxime and Sulbactam Sodium for Injection (2:1) for Treatment of Respiratory and Urinary Tract Infection
NCT01426191 ·Status: COMPLETED
-
Prolonged Infusion Cefepime and Nosocomial Infections
NCT02568800 ·Status: UNKNOWN ·Phase: PHASE3
-
Pharmacokinetics of Vancomycin in Adults Receiving ECMO
NCT00281281 ·Status: COMPLETED ·Phase: PHASE4
-
Beta-lactam Therapeutic Drug Monitoring in Singapore
NCT04450680 ·Status: UNKNOWN
-
Beta-lactams Therapeutic Drug Monitoring in Critically Ill Patients
NCT05352997 ·Status: COMPLETED
-
Daptomycin or Vancomycin in Treating Bacteria in the Blood in Patients With Neutropenia Caused By Chemotherapy
NCT00296049 ·Status: WITHDRAWN ·Phase: NA
-
Effect of Antibiotic Choice On ReNal Outcomes (ACORN)
NCT05094154 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of Colistimethate Sodium for Injection in The Treatment of Carbapenem-Resistant Enterobacteriaceae Infection
NCT06051513 ·Status: RECRUITING ·Phase: NA
-
Molecular Characterization of Carbapenemase-Producing Enterobacterales
NCT07116356 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Model-informed Precision Dosing of Vancomycin in Adults
NCT05535075 ·Status: COMPLETED ·Phase: PHASE4
-
Treatment Algorithm to Reduce the Use of Vancomycin in Adults With Blood Stream Infection
NCT01191840 ·Status: COMPLETED ·Phase: PHASE2
-
Seven Versus 14 Days of Antibiotic Therapy for Multidrug-resistant Gram-negative Bacilli Infections
NCT05210387 ·Status: TERMINATED ·Phase: NA
-
Pharmacokinetics/ Pharmacodynamics (PK/PD) Study of Vancomycin
NCT02443064 ·Status: UNKNOWN ·Phase: PHASE4
-
Population Pharmacokinetics of Anti-infectives in Hospitalized Patients
NCT02998411 ·Status: RECRUITING
-
Effectiveness of Vancomycin Loading Therapy
NCT01623817 ·Status: COMPLETED ·Phase: NA